Last Posted: Sep 27, 2019
- Don't think twice it's all right: tamoxifen and CYP2D6 genotyping in the treatment of breast cancer patients.
Damkier Per et al. Pharmacogenomics 2017 Jun 18(8) 753-754 - Effect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplay.
Sim Sarah et al. Pharmacogenomics 2018 19(13) 1027-1037 - Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.
Raimondi Alessandra et al. Pharmacogenomics 2018 19(13) 1047-1068 - Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
Cousin Margot A et al. Molecular genetics & genomic medicine 2017 May 5(3) 269-279 - Pharmacogenomics: What the Doctor Ordered?
Eissenberg Joel C et al. Missouri medicine 116(3) 217-225 - Should CYP2D6 be genotyped when treating with tamoxifen?
Del Re Marzia et al. Pharmacogenomics 2017 Jun 18(8) 755-756 - The Pharmacogenomics of Inhaled Corticosteroids and Lung Function Decline in COPD.
Obeidat Ma'en et al. The European respiratory journal 2019 Sep - From the Origins of Pharmacogenetics to First Applications in Psychiatry.
Müller Daniel J et al. Pharmacopsychiatry 2019 Sep - PharmVar GeneReview: CYP2D6.
Nofziger Charity et al. Clinical pharmacology and therapeutics 2019 Sep - Advances in the Pharmacogenomics of Antiplatelet Therapy.
Akhtar Tauseef et al. American journal of therapeutics 2019 Sep
No hay comentarios:
Publicar un comentario